Thomas Hohman, PhD
Thomas Hohman, PhD, earned his PhD from the University of California, Los Angeles (UCLA), and completed postdoctoral fellowships at the National Heart, Lung, and Blood Institute and the National Eye…
Alice Randon
Alice (born in 1999) holds a Master’s degree in pharmaceutical biotechnology from the University of Milan. After graduation, she joined the National Insitute of Molecular Genetics (INGM) in Milan as a…
Adriaan Aarts
Adriaan (born in 1965) studied Economics at Tilburg University and began his career in banking. After spending two years at Citigroup in Zurich and Paris, he joined ABN AMRO, where…
Camiel J.F. Boon, MD, PhD
Camiel Boon, MD, PhD, FEBO, is a Consultant Ophthalmologist at Amsterdam University Medical Centers and at Leiden University Medical Center (the Netherlands). Already at the age of 36, he was…
Maarten Scholten
After obtaining his law degree at the University of Amsterdam (The Netherlands), Mr. Scholten started his career as an attorney at the Amsterdam and New York offices of Loeff &…
Carel Hoyng, MD, PhD
“My ultimate goal is to find a cure for inherited retinal diseases”
Rob Collin, PhD
“Due to their high specificity, antisense oligonucleotides hold great promise to correct RNA defects underlying many inherited diseases”
Erwin van Wijk, PhD
"Being able to save vision will be a life-changing event for people with a blinding disorder"
Melita Kaltak, PhD
"I'm committed to helping develop solutions for individuals with vision disorders. My goal is to advance antisense oligonucleotides from research to clinical trials, making a difference in the lives of the community affected by Stargardt disease and Usher syndrome."
Femke Bukkems
"By researching treatment for retinal disorders, I hope to help and eventually cure patients with these diseases so that they can once again enjoy all that is happening around them."